Evidence map›Paper›PMID 32494835›Full record

ArticleCardiovascular and interventional radiology2020

Prostatic Artery Embolization Allows to Maintain Full Sexual Activity in Patients Suffering from Bothersome Lower Urinary Tracts Symptoms related to Benign Prostatic Hyperplasia.

Ludovica Marzano, Nicolas Thiounn, Helena Pereira, Olivier Pellerin, Charles Dariane, Costantino Del Giudice, Gregory Amouyal, Carol Dean, Marc Sapoval

Abstract read
PubMed Publisher
In one paragraph

Article in Cardiovascular and interventional radiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ludovica MarzanoVascular and Oncological Interventional Radiology Department Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France. Ludovica.Marzano@eoc.ch.ORCID http://orcid.org/0000-0002-1709-8724
Nicolas ThiounnFaculté de Médecine, Université Paris V: René Descartes, Paris, France.
Helena PereiraClinical Research Unit Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
Olivier PellerinFaculté de Médecine, Université Paris V: René Descartes, Paris, France.
Charles DarianeUrology Department Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
Costantino Del GiudiceFaculté de Médecine, Université Paris V: René Descartes, Paris, France.
Gregory AmouyalHôpital Saint Louis, Paris, France.
Carol DeanVascular and Oncological Interventional Radiology Department Assistance Publique - Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Paris, France.
Marc SapovalFaculté de Médecine, Université Paris V: René Descartes, Paris, France. marc.sapoval2@aphp.fr.
Délégation Paris 5 · FRAssistance Publique – Hôpitaux de Paris · FRInserm · FRHôpital Saint-Louis · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThe effect of prostate artery embolization (PAE) on male sexual function is currently the subject of debate in the literature. The main purpose of this study was to define changes in all domains of sexual activity after PAE, using the international index of erectile function score (IIEF-15).

methodsA single-center retrospective study was conducted on 129 patients (mean age of 65.5 ± 7 years), who underwent PAE from February 2014 to January 2017 for symptomatic benign prostatic hyperplasia (BPH). Fifty consecutive patients fulfilling the inclusion criteria were evaluated before and after PAE follow-up using the IIEF-15, IPSS, prostate volume (PV) and cardiovascular risk factor and BPH drugs. The IIEF-15 domains analyzed were: erectile function (EF) ejaculation and orgasm (Ej/O), sexual desire (SD), intercourse satisfaction (IS) and overall satisfaction (OS). A paired sample t test or Wilcoxon signed-rank test was used to compare IIEF-15 between baseline and follow-up.

resultsThe study showed nonsignificant change in IIEF-15 total score (58.0 ± 13.8 SD; p = 0.71) and the five domains (EF 24.5 ± 7.0 SD, p = 0.82; EJ/O 8.2 ± 2.3 SD, p = 0.50; SD 7.2 ± 2.7 SD, p = 0.57; IS 10.3 ± 3.0 SD, p = 0.77; OS 8.2 ± 2.7 SD; p = 0.11) after PAE. We also found a significant improvement in IPSS score after PAE.

conclusionBased on the IIEF-15 questionnaire, PAE was showed to allow good urinary symptoms results and no deterioration in sexual function.

Indexed as

AgedAged, 80 and overEmbolization, TherapeuticErectile DysfunctionHumansLower Urinary Tract SymptomsMaleMiddle AgedProstateProstatic HyperplasiaRetrospective StudiesSexual BehaviorSurveys and QuestionnairesTreatment OutcomeInternational index of erectile function-15 (IIEF-15)International prostate symptom score (IPSS)Lower urinary tract symptoms (LUTS)Prostatic artery embolization (PAE)Sexual dysfunctionSymptomatic benign prostatic hyperplasia (BPH)Transurethral resection of the prostate (TURP)

Identifiers

PMID32494835
OpenAlexW3031951959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.